Porosome India

 Revolutionizing medicines 
● Driving next frontier in healthcare

 Building pathways to cures

About Porosome Therapeutics India Pvt. Ltd.
Porosome Therapeutics India Pvt. Ltd. is a subsidiary of Boston-based Porosome Therapeutics, Inc.
https://www.porosome.com

Breakthrough Therapies Using Porosome-Targeted AI Engines 
https://www.youtube.com/watch?v=zCRbeHH-kBY
https://files.cdn-files-a.com/uploads/5744411/normal_6a0ce1a8ef121.mp4
  
  • Alzheimer’s Reversal
  • Cystic Fibrosis
  • Infectious Disease (Enveloped Virus Preventive)
Platform
The discovery of the ‘porosome’, the cell's secretory apparatus, has provided a platform for entry into a new era in drug development and therapy. The porosome has been isolated, its structure and composition determined, and it has been functionally reconstituted into live cells. Many diseases including Alzheimer’s and cystic fibrosis, result from secretory defects in the porosome. Undruggable porosome protein targets can now be addressed by incorporating the native functional porosome into diseased cells. Using cryo-EM and AI, the atomic structure of the neuronal porosome is being solved, that has allowed precision-targeting of small molecules to modulate secretory disorder, thereby treating the disease.



Porosome Therapeutics has ongoing collaborative research globally:

 https://www.porosome.com/about-us/collaborations


PATENERSHIP with CSIR, INDIA

The Council of Scientific & Industrial Research (CSIR) of the Government of India, is a world class premier R&D organization known for its cutting-edge R&D knowledge base in diverse S&T fields. CSIR’s R&D expertise and experience are embodied in about 3476  Scientists supported by about 4000 technical and support personnel as of 31st March 2022. [https://www.csir.res.in/en/about-us/about-csir].



  • Porosome Therapeutics India Private Limited. AWFIS, Ginger Hotel, Opposite Nalco Headquarters, Nayapalli, Plot - H, Jayadev Vihar, Bhubaneswar 751013, Odisha, India.